Key features and details
- Rabbit polyclonal to PSCA, prediluted
- Suitable for: IHC-P
- Reacts with: Human
- Isotype: IgG
Product nameAnti-PSCA antibody, prediluted
See all PSCA primary antibodies
DescriptionRabbit polyclonal to PSCA, prediluted
Tested applicationsSuitable for: IHC-Pmore details
Species reactivityReacts with: Human
Synthetic peptide within Human PSCA (extracellular). The exact sequence is proprietary.
Database link: O43653
- Bladder carcinoma and Prostate carcinoma.
This product is FOR RESEARCH USE ONLY. For commercial use, please contact email@example.com.
Storage instructionsShipped at 4°C. Store at +4°C.
Storage bufferpH: 7.60
Preservative: 0.1% Sodium azide
Constituents: Tris buffered saline, 1% BSA
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab15169 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/1. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.|
RelevancePSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40% of primary prostate cancers and in as many as 100% of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
Cellular localizationCell membrane; Lipid-anchor, GPI-anchor.
- PRO 232 antibody
- PRO232 antibody
- Prostate stem cell antigen antibody
ab15169 has been referenced in 1 publication.
- Taeb J et al. Expression of prostate stem cell antigen (PSCA) in prostate cancer: A tissue microarray study of Iranian patients. Pathol Res Pract N/A:N/A (2013). IHC-P ; Human . PubMed: 24183365